Login / Signup

Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.

Qian WangYibin JiangQian ZhuYishan DuanXiaochen ChenTing XuZhengming JinCaixia LiDepei WuHaiwen Huang
Published in: Journal of cancer research and clinical oncology (2021)
Hepatosplenic γ δ T-cell lacks a standard therapy and is often refractory to conventional chemotherapy regimens. Intensive induction chemotherapy followed by hematopoietic cell transplantation may improve the prognosis of HSTCL.
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • chemotherapy induced
  • radiation therapy